The U.S.-based vaccine manufacturer Moderna Inc. will be building a plant in Canada after signing a memorandum of understanding with the Canadian government this week.
Topic: Canada's vaccine manufacturing capability
The Short Report – June 23, 2021: Construction finishes on Biologic’s vaccine plant, a new interdisciplinary school of health at Concordia, quantum research funding in Quebec and more
Minister Champagne announces construction of NRC’s vaccine plant in Montreal is complete, Concordia gets go-ahead for a new school of interdisciplinary health, NISC receives quantum research funding to improve online communication security, and more.
Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.